456160 G2GBIO, Inc. KRX · South Korea

G2GBIO (456160) news

G2GBIO, Inc. is a public biotech or pharmaceutical company listed on KRX under the ticker 456160, recorded under South Korea. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest G2GBIO news

We have not published a story on G2GBIO yet. When there is news, it will appear here.

Questions about G2GBIO

What is the ticker symbol of G2GBIO?

G2GBIO, Inc. trades under the ticker 456160 on KRX.

Where is G2GBIO listed?

G2GBIO, Inc. is listed on KRX.

Which country or territory is G2GBIO listed under?

Our directory records G2GBIO, Inc. under South Korea.

What does G2GBIO do?

Our directory classifies G2GBIO, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of G2GBIO?

The ISIN recorded for G2GBIO, Inc. is KR7456160001.

Does aibio.space cover G2GBIO?

aibio.space lists G2GBIO, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to G2GBIO?

Companies in our directory listed in the same country and business area as G2GBIO: GenoTech, Quratis, Xcell Therapeutics, Naturalendo Tech Co., SillaJen, IMBiologics.

Investor discussion: G2GBIO

Members talk about G2GBIO (456160). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:456160 on TradingView.

Listing details

Company: G2GBIO, Inc.
Ticker: 456160
Listing: KRX
Country or territory: South Korea
Business scope: Biotechnology
ISIN: KR7456160001
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction